Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / China Grand Pharmaceutical — Sirtex Medical
Entity

China Grand Pharmaceutical — Sirtex Medical

Tracked across 1 events · 8 articles · First seen Apr 13, 2026 · Last active May 14, 2026

Sentiment
80
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 80
Tech
Sirtex Medical DOORwaY90 Study Success
Impact: China Grand Pharmaceutical — Sirtex Medical announced landmark 12-month results from its DOORwaY90 study, demonstrating high efficacy of its SIR-Spheres Y-90 resin microspheres in treating unresectable hepatocellular carcinoma (HCC). This positive outcome is expected to significantly boost the company's market position and product adoption.
Apr 13, 2026 · 8 articles
ERGEN INTELLIGENCE
Track China Grand Pharmaceutical — Sirtex Medical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.